GLP-1 and Metabolic Therapies

Semaglutide

GLP-1 receptor agonist used for appetite regulation and metabolic control.

Tirzepatide

Dual GIP and GLP-1 agonist supporting glycemic control and weight reduction.

Retatrutide

Triple agonist therapy affecting GLP-1, GIP, and glucagon pathways.

Cagrilintide

Amylin analog studied for appetite suppression and metabolic regulation.

AOD 9604

Growth hormone fragment studied for fat metabolism signaling.

5-Amino-1MQ

NNMT inhibitor studied for metabolic regulation and fat metabolism.

Tesofensine

Monoamine reuptake inhibitor studied for appetite suppression and weight management.

Survodutide

Dual GLP-1 and glucagon receptor agonist studied for advanced metabolic regulation.